It is possible that eIF4Ai further contributes to AML cell death by reducing levels of the anti-apoptotic proteins BCL2, BCL-XL and MCL1 that control mitochondrial function and integrity [86]. This evidence concerns the gene BCL2 and acute myeloid leukemia.